Delivery Order SPE2DB22D2007-SPE2DB24FJ2PM
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,671.02 delivery order contract is for the supply of Valsartan-HCTZ 160-12.5 mg tablets. The contract has a firm fixed price, with an ultimate completion date of December 12, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,225.26, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract is a Firm Fixed Price Delivery Order with a completion date of March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,424.29, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,312.55 firm fixed-price delivery order is for the supply of Valsartan-HCTZ 80-12.5 mg tablets. The contract has an ultimate completion date of August 13, 2024 and does not utilize a set-aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,857.43, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets over a period ending on June 13, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a $10,545.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Valsartan-HCTZ 320-25 mg tablets. The contract is not designated as a set-aside and has an ultimate completion date of June 7, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,940.38, is a Firm Fixed Price Delivery Order for the supply of Valsartan-HCTZ 160-25 mg tablets. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,615.47, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of June 5, 2024 and is a firm fixed-price delivery order. This award does not have a set-aside designation, indicating it was open competition. AmerisourceBergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,233.01, is for the delivery of Valsartan-HCTZ 320-25 mg tablets in quantities of 90. This is a firm fixed-price delivery order contract with an ultimate completion date of March 5, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,652.05, is a Firm Fixed Price Delivery Order for the supply of the drug Valsartan-HCTZ 160-12.5 mg tablets. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FJ2PMDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,220.05, is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The contract has a firm fixed price structure and a period of performance ending on May 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 5/15/24 |